Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-10-07
1994-08-16
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544284, 544287, A61K 31505, C07D23990, C07D23991
Patent
active
053387368
ABSTRACT:
This disclosure describes novel 2,3,6-substituted quinazolinones of the formula: ##STR1## where R.sup.6, R.sup.5 and R are described in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5202322 (1993-04-01), Allen
patent: 5204354 (1993-04-01), Chakravarty et al.
patent: 5238942 (1993-08-01), Chakravarty et al.
patent: 5240928 (1993-08-01), Allen et al.
patent: 5281602 (1994-01-01), Newman
patent: 5281603 (1994-01-01), Venkatesan
patent: 5281604 (1994-01-01), Levin
patent: 5284852 (1994-02-01), Levin
patent: 5284853 (1994-02-01), Levin
patent: 5286729 (1994-02-01), Levin
patent: 5288720 (1994-02-01), Albright
patent: 5290780 (1994-03-01), Venkatesan
patent: 5292734 (1994-03-01), Levin
patent: 5292742 (1994-03-01), Venkatesan
patent: 5294611 (1994-03-01), Venkatesan
patent: 5294617 (1994-03-01), Venkatesan
patent: 5296480 (1994-03-01), Newman
U.S. Pat. Appl. No. 08/052,945 Levin filed Apr. 23, 1993.
American Cyanamid Company
Grumbling Matthew V.
Shah Mukund J.
Szatkowski Thomas
LandOfFree
Angiotensin II receptor blocking 2,3,6-substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3,6-substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6-substituted quinazolinone will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-951984